Skip to main content
SpringerLink
Log in

Craniopharyngioma and Eating Disorders

  • Chapter
  • First Online:
Hidden and Lesser-known Disordered Eating Behaviors in Medical and Psychiatric Conditions

  • 1090 Accesses

Abstract

Craniopharyngiomas (CPs) are rare brain tumours arising from the craniopharyngeal duct epithelium, with a bimodal peak incidence (5–15 years old and 50–74 years old). Primary clinical manifestations are visual impairment and endocrine deficits. Treatment comprises neurosurgery and radiotherapy and intracystic treatments in selected cases. A wide range of endocrine or neurological complications follow the treatment. Damage to the hypothalamus can result in a syndrome of hypothalamic obesity, which is typically a morbid obesity, resistant to basic weight loss interventions and contributing to the increased mortality of CP patients. Eating disorders play an important role in the pathogenesis of obesity, but other factors such as psychosocial disorders, sleep disturbances, decreased energy expenditure, hyperinsulinemia, and hypopituitarism should be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Müller HL. Craniopharyngioma. Endocr Rev. 2014;35:513–43.

    Article  Google Scholar 

  2. Müller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S. Craniopharyngioma. Nat Rev Dis Primers. 2019;5:75.

    Article  Google Scholar 

  3. Khan RB, Merchant TE, Boop FA, et al. Headaches in children with craniopharyngioma. J Child Neurol. 2013;28:1622.

    Article  Google Scholar 

  4. Garnett MR, Puget S, Grill J, Sainte-Rose C. Craniopharyngioma. Orphanet J Rare Dis. 2007;2:18.

    Article  Google Scholar 

  5. Honegger J, Tatagiba M. Craniopharyngioma surgery. Pituitary. 2008;11:361.

    Article  Google Scholar 

  6. Lustig RH. Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment. Front Endocrinol. 2011;2:1–8.

    Article  Google Scholar 

  7. Li X, Wu W, Miao Q, He M, Zhang S, Zhang Z, Lu B, Yang Y, Shou X, Li Y, Wang Y, Ye H. Endocrine and metabolic outcomes after transcranial and endoscopic endonasal approaches for primary resection of craniopharyngiomas. World Neurosurg. 2019;121:e8–e14.

    Article  Google Scholar 

  8. Olsson DS, Andersson E, Bryngelsson IL, et al. Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden. J Clin Endocrinol Metab. 2015;100:467.

    Article  CAS  Google Scholar 

  9. Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbuchel AMM, Muller HL. Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro Oncol. 2015;17:1029–38.

    Article  Google Scholar 

  10. Rosenfeld A, Arrington D, Miller J, Olson M, Gieseking A, Etzl M, Harel B, Schembri A, Kaplan AA. Review of childhood and adolescent craniopharyngiomas with particular attention to hypothalamic obesity. Pediatr Neurol. 2014;50:4–10.

    Article  Google Scholar 

  11. Müller HL. Consequences of craniopharyngioma surgery in children. J Clin Endocrinol Metab. 2011;96:1981–91.

    Article  Google Scholar 

  12. van Iersel L, Brokke KE, Adan RAH, Bulthuis LCM, van den Akker ELT, van Santen HM. Pathophysiology and individualized treatment of hypothalamic obesity following craniopharyngioma and other suprasellar tumors: a systematic review. Endocr Rev. 2019;40:193–235.

    Article  Google Scholar 

  13. Fouda MA, Zurakowski D, Scott RM, Marcus KJ, Manley PE, Ullrich NJ, Cohen LE, Goumnerova LC. Novel predictive scoring system for morbid hypothalamic obesity in patients with pediatric craniopharyngioma. Childs Nerv Syst. 2021;37:403–10.

    Article  Google Scholar 

  14. Hidalgo ET, Orillac C, Kvint S, McQuinn MW, Dastagirzada Y, Phillips S, Wisoff JH. Quality of life, hypothalamic obesity, and sexual function in adulthood two decades after primary gross-total resection for childhood craniopharyngioma. Childs Nerv Syst. 2020;36:281–9.

    Article  Google Scholar 

  15. Chemaitilly W, Armstrong GT, Gajjar A, Hudson MM. Hypothalamic-pituitary axis dysfunction in survivors of childhood cns tumors: importance of systematic follow-up and early endocrine consultation. J Clin Oncol. 2016;34:4315–9.

    Article  Google Scholar 

  16. Fjalldal S, Follin C, Gabery S, Sundgren PC, Björkman-Burtscher IM, Lätt J, Mannfolk P, Nordström CH, Rylander L, Ekman B, Cheong R, Pålsson A, Petersén Å, Erfurth EM. Detailed assessment of hypothalamic damage in craniopharyngioma patients with obesity. Int J Obes (Lond). 2019;43:533–44.

    Article  CAS  Google Scholar 

  17. Lustig RH. Autonomic dysfunction of the b-cell and the pathogenesis of obesity. Rev Endocr Metab Disord. 2003;4:23–32.

    Article  CAS  Google Scholar 

  18. Müller HL. Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity. Curr Opin Endocrinol Diabetes Obes. 2016;23:81–9.

    Article  Google Scholar 

  19. Roth CL, Gebhardt U, Müller HL. Appetite-regulating hormone changes in patients with craniopharyngioma. Obesity (Silver Spring). 2011;19:36–42.

    Article  CAS  Google Scholar 

  20. Daubenbüchel AM, Özyurt J, Boekhoff S, Warmuth-Metz M, Eveslage M, Müller HL. Eating behaviour and oxytocin in patients with childhood-onset craniopharyngioma and different grades of hypothalamic involvement. Pediatr Obes. 2019;e12527:14.

    Google Scholar 

  21. Roth CL. Hypothalamic obesity in patients with craniopharyngioma: profound changes of several weight regulatory circuits. Front Endocrinol (Lausanne). 2011;2:49.

    Article  Google Scholar 

  22. Hrz KC, Müller HL, Waldeck R, Pudel V, Roth C. Obesity in patients with Craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab. 2003;88:5227–31.

    Article  Google Scholar 

  23. Onofri A, Ambrosio MR, Bondanelli M, Leoni M, Carli A, De Paola G, Manzato E, degli Uberti EC. Binge eating disorder in patients operated for craniopharyngioma. J Endocrinol Invest. 2006;29, Suppl.to n. 4.

    Google Scholar 

  24. Müller HL, Heinrich M, Bueb K, Etavard-Gorris N, Gebhardt U, Kolb R, Sörensen N. Perioperative dexamethasone treatment in childhood craniopharyngioma: influence on short-term and long-term weight gain. Exp Clin Endocrinol Diabetes. 2003;111:330–4.

    Article  Google Scholar 

  25. Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH. Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:3888–921.

    Article  CAS  Google Scholar 

  26. Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103:1715–44.

    Article  Google Scholar 

  27. Heinks K, Boekhoff S, Hoffmann A, Warmuth-Metz M, Eveslage M, Peng J, Calaminus G, Müller HL. Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007. Endocrine. 2018;59:364–72.

    Article  CAS  Google Scholar 

  28. Boekhoff S, Bogusz A, Sterkenburg AS, Eveslage M, Muller HL. Long- term effects of growth hormone replacement therapy in childhood onset craniopharyngioma: results of the German craniopharyngioma registry (HIT- Endo). Eur J Endocrinol. 2018;179:331–41.

    Article  CAS  Google Scholar 

  29. Elfers CT, Roth CL. Effects of methylphenidate on weight gain and food intake in hypothalamic obesity. Front Endocrinol (Lausanne). 2011;2:78.

    Article  Google Scholar 

  30. Tzotzas T, Papazisis K, Perros P, Krassas GE. Use of somatostatin analogues in obesity. Drugs. 2008;68:1963–73.

    Article  CAS  Google Scholar 

  31. Durrer Schutz D, Busetto L, Dicker D, Farpour-Lambert N, Pryke R, Toplak H, Widmer D, Yumuk V, Schutz Y. European practical and patient-centred guidelines for adult obesity management in primary care. Obes Facts. 2019;12:40–66.

    Article  Google Scholar 

  32. Ni W, Shi X. Interventions for the treatment of craniopharyngioma-related hypothalamic obesity: a systematic review. World Neurosurg. 2018;118:e59–71.

    Article  Google Scholar 

  33. Bretault M, Boillot A, Muzard L, Poitou C, Oppert JM, Barsamian C, Gatta B, Müller H, Weismann D, Rottembourg D, Inge T, Veyrie N, Carette C, Czernichow S. Clinical review: bariatric surgery following treatment for craniopharyngioma: a systematic review and individual-level data meta-analysis. J Clin Endocrinol Metab. 2013;98:2239–46.

    Article  CAS  Google Scholar 

  34. Garrez I, Lapauw B, Nieuwenhove YV. Bariatric surgery for treatment of hypothalamic obesity after craniopharyngioma therapy: a matched case–control study. Obes Surg. 2020;30:2439–44.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Endocrinology & Internal Medicine, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy

    Marta Bondanelli, Irene Gagliardi & Maria Rosaria Ambrosio

  2. Formerly University of Ferrara, Chief Eating Disorders Unit, Private Hospital “Salus”, Ferrara, Italy

    Emilia Manzato

Authors
  1. Marta Bondanelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emilia Manzato
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Irene Gagliardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Rosaria Ambrosio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marta Bondanelli .

Editor information

Editors and Affiliations

  1. Private Hospital "Salus" of Ferrara, University of Ferrara, Ferrara, Italy

    Emilia Manzato

  2. Formerly Sapienza University of Rome, Founding Editor of Eating and Weight Disorders, Campiglia Marittima, Livorno, Italy

    Massimo Cuzzolaro

  3. Experimental Medicine Department, Sapienza University of Rome, Editor-in-Chief of Eating and Weight Disorders, Roma, Roma, Italy

    Lorenzo Maria Donini

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bondanelli, M., Manzato, E., Gagliardi, I., Ambrosio, M.R. (2022). Craniopharyngioma and Eating Disorders. In: Manzato, E., Cuzzolaro, M., Donini, L.M. (eds) Hidden and Lesser-known Disordered Eating Behaviors in Medical and Psychiatric Conditions . Springer, Cham. https://doi.org/10.1007/978-3-030-81174-7_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-81174-7_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-81173-0

  • Online ISBN: 978-3-030-81174-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation